JAK Inhibitors Pose Higher Infection Risk vs Biological DMARDs in Rheumatoid Arthritis

Retrieved on: 2024-06-24 21:24:30

Tags for this article:

Autoimmune diseases

Arthritis

Rheumatology

Janus kinase inhibitor

Rheumatoid arthritis

Disease-modifying antirheumatic drug

Herpes

Antiarthritics

Click the tags to see associated articles and topics

JAK Inhibitors Pose Higher Infection Risk vs Biological DMARDs in Rheumatoid Arthritis. View article details on hiswai:

Excerpt

More comprehensive, long-term studies are needed to accurately gauge infection risks across different RA patient groups. In a retrospective cohort ...

Article found on: www.rheumatologyadvisor.com

View Original Article